Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (Shanchol) in Subjects Aged 1 Year and Older in Dominican Republic
Phase of Trial: Phase III
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 23 Aug 2016 Status changed from active, no longer recruiting to completed.
- 29 Sep 2015 Planned End Date changed from 1 Mar 2016 to 1 Jul 2016 as per ClinicalTrials.gov record.
- 29 Sep 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.